Andrew E. Hogan

4.7k citations

76 papers · 3.7k · 1 hit paper · h-index 32

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- Immunotherapy and Immune Responses
Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases

Papers in

Immunology 47
- Immune Cell Function and Interaction 36
- T-cell and B-cell Immunology 16
- IL-33, ST2, and ILC Pathways 11
- Immune cells in cancer 5
- Immunotherapy and Immune Responses 4
Epidemiology 16
- Adipokines, Inflammation, and Metabolic Diseases 12

Co-authors: Donal O’Shea (45 shared papers)Lydia Lynch (11 shared papers)Jean O’Connell (10 shared papers)Mark A. Exley (6 shared papers)Cliona O’Farrelly (4 shared papers)Michelle A. Corrigan (6 shared papers)Derek G. Doherty (8 shared papers)Vincent P. O’Reilly (6 shared papers)
Journals: The Journal of Immunology (6 papers)Frontiers in Immunology (5 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Immunity (3 papers)Obesity (3 papers)
Partner nations: Ireland United States United Kingdom

In The Last Decade

Andrew E. Hogan

70 papers receiving 3.7k citations

Andrew E. Hogan's Hit Papers

align trajectories log scale

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses 2018 · 504 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2018 Nature Immunology

Peers

Countries citing papers authored by Andrew E. Hogan

Since Specialization

Citations

This map shows the geographic impact of Andrew E. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Hogan more than expected).

Fields of papers citing papers by Andrew E. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Hogan. The network helps show where Andrew E. Hogan may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew E. Hogan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew E. Hogan Line = papers co-authored together Andrew E. Hogan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Metabolic reprogramming of natural killer cells in obesity limits antitumor responses Nature Immunology ·Xavier Michelet, Lydia Dyck, Andrew E. Hogan, Róisín M. Loftus, Danielle Duquette, Kevin S. Wei, Semir Beyaz, Ali Tavakkoli Hit paper breakdown →	2018	504
2	Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production Immunity ·Lydia Lynch, Michael A. Nowak, Bindu Varghese, Justice Clark, Andrew E. Hogan, Vasillis Toxavidis, Steven P. Balk, Donal O’Shea	2012	422
3	Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus Diabetologia ·Andrew E. Hogan, Gadintshware Gaoatswe, Lydia Lynch, Michelle A. Corrigan, Conor P. Woods, Jean O’Connell, Donal O’Shea	2013	207
4	Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity Immunity ·Selma Boulenouar, Xavier Michelet, Danielle Duquette, DAVID PONFERRADA ÁLVAREZ, Andrew E. Hogan, Christina Dold, Donal B O’Connor, Suzanne Stutte	2017	161
5	Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis Diabetologia ·Andrew E. Hogan, Anne‐Marie Tobin, Tomás Ahern, M. Corrigan, Gadinthsware Gaoatswe, Ruaidhrí P. Jackson, Vincent P. O’Reilly, Lydia Lynch	2011	155
6	iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy Cell Metabolism ·Lydia Lynch, Andrew E. Hogan, Danielle Duquette, Chantel Lester, Alexander S. Banks, Katherine B. LeClair, David E. Cohen, Abhisek Ghosh	2016	153
7	Altered Distribution and Increased IL-17 Production by Mucosal-Associated Invariant T Cells in Adult and Childhood Obesity The Journal of Immunology ·Eirin Carolan, Laura M. Tobin, Bozgana A. Mangan, Michelle A. Corrigan, Gadinthsware Gaoatswe, Greg Byrne, Justin Geoghegan, Declan Cody	2015	149
8	Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human Vδ3 T Cells The Journal of Immunology ·Bozgana A. Mangan, Margaret R. Dunne, Vincent P. O’Reilly, Pádraic J. Dunne, Mark A. Exley, Donal O’Shea, Emmanuel Scotet, Andrew E. Hogan	2013	143
9	Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer PLoS ONE ·Adriana J. Michielsen, Andrew E. Hogan, Joseph Marry, Miriam Tosetto, Fionnuala Cox, John M. Hyland, Kieran D. Sheahan, Diarmuid P. O’Donoghue	2011	108
10	NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient JCI Insight ·Laura M. Tobin, Meenal Mavinkurve, Eirin Carolan, David Kinlen, Eóin C. O’Brien, Mark Alan Little, David K. Finlay, Declan Cody	2017	97
11	Dysregulation of Natural Killer Cells in Obesity Cancers ·Donal O’Shea, Andrew E. Hogan	2019	90
12	Distinct and Overlapping Effector Functions of Expanded Human CD4+, CD8α+ and CD4-CD8α- Invariant Natural Killer T Cells PLoS ONE ·Vincent P. O’Reilly, Shijuan G. Zeng, Gabriel Bricard, Ann Atzberger, Andrew E. Hogan, John F. Jackson, Conleth Feighery, Steven Anthony Porcelli	2011	84
13	The Impact of Childhood Obesity on Inflammation, Innate Immune Cell Frequency, and Metabolic MicroRNA Expression The Journal of Clinical Endocrinology & Metabolism ·Eirin Carolan, Andrew E. Hogan, Michelle A. Corrigan, Gadintshware Gaotswe, Jean O’Connell, Niamh H. Foley, Luke A.J. O'Neill, Declan Cody	2013	82
14	The helminth T2 RNase ω1 promotes metabolic homeostasis in an IL‐33‐ and group 2 innate lymphoid cell‐dependent mechanism The FASEB Journal ·Emily Hams, Rachel Bermingham, Felicity A. Wurlod, Andrew E. Hogan, Donal O’Shea, Roger J. S. Preston, Hans‐Reimer Rodewald, Andrew N. J. McKenzie	2015	75
15	Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function The Journal of Experimental Medicine ·Lydia Dyck, Hannah Prendeville, Mathilde Raverdeau, Mieszko M. Wilk, Róisín M. Loftus, Aaron Douglas, Janet McCormack, Bruce Moran	2022	73
16	Glucagon‐like peptide‐1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study Journal of the European Academy of Dermatology and Venereology ·Tomás Ahern, Anne‐Marie Tobin, M. Corrigan, Andrew E. Hogan, Cheryl M. Sweeney, Brian Kirby, Donal O’Shea	2012	72
17	Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection International Journal of Obesity ·Donal O’Shea, M. Corrigan, Margaret R. Dunne, Robert Wilson Jackson, Conor P. Woods, Gadintshware Gaoatswe, Paul N. Moynagh, Jean O’Connell	2013	63
18	Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction Nature Communications ·Eirini Giannoudaki, Yasmina Hernandez-Santana, Kelly Mulfaul, Sarah Doyle, Emily Hams, Padraic G. Fallon, Arimin Mat, Donal O’Shea	2019	57
19	Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses The Journal of Immunology ·Aisling O’Brien, Róisín M. Loftus, Marta M. Pisarska, Laura M. Tobin, Ronan Bergin, Nicole Wood, Cathriona Foley, Arimin Mat	2019	56
20	Preadipocyte Factor-1 Is Associated with Metabolic Profile in Severe Obesity The Journal of Clinical Endocrinology & Metabolism ·Jean O’Connell, Lydia Lynch, Andrew E. Hogan, Tom Cawood, Donal O’Shea	2011	54

About Andrew E. Hogan

Andrew E. Hogan is a scholar working on Immunology, Epidemiology, Oncology, Dermatology and Endocrinology, Diabetes and Metabolism, having authored 76 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (36 papers), T-cell and B-cell Immunology (16 papers), Adipokines, Inflammation, and Metabolic Diseases (12 papers), IL-33, ST2, and ILC Pathways (11 papers), CAR-T cell therapy research (5 papers), Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Immunology (1.9k citations), Epidemiology (941 citations), Physiology (619 citations), Endocrinology, Diabetes and Metabolism (342 citations) and Oncology (444 citations). Andrew E. Hogan has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Donal O’Shea, Lydia Lynch, Jean O’Connell, Mark A. Exley, Cliona O’Farrelly, Michelle A. Corrigan, Derek G. Doherty, Vincent P. O’Reilly, Gadintshware Gaoatswe and Danielle Duquette. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, The Journal of Clinical Endocrinology & Metabolism, Immunity and Obesity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Andrew E. Hogan

Impact in

Papers in i

In The Last Decade

Andrew E. Hogan

Andrew E. Hogan's Hit Papers

Peers

Countries citing papers authored by Andrew E. Hogan

Fields of papers citing papers by Andrew E. Hogan

All Works

About Andrew E. Hogan

Explore authors with similar magnitude of impact

Papers in